ERIE Form 4: 17.168 credits added; 1,725 shares held post-update
Rhea-AI Filing Summary
Erie Indemnity (ERIE) reported a routine insider update. On 10/21/2025, a director was credited 17.168 Directors' Deferred Compensation Share Credits under dividend reinvestment, coded J. These credits represent the right to receive an equal number of Class A shares when board service ends and have no exercise or expiration dates.
The filing lists a reference price of $325.89 for the derivative entry. Following the report, the director holds 1,725 Class A shares directly and 3,997.35 share credits.
Positive
- None.
Negative
- None.
Insights
Routine Form 4; non-cash share credits via dividend reinvestment.
This update records 17.168 Directors' Deferred Compensation Share Credits acquired on 10/21/2025 under dividend reinvestment, labeled transaction code J. These credits entitle the holder to receive an equal number of Class A shares after board service ends, with no exercise or expiration dates stated.
The derivative table shows a reference price of $325.89. Post-transaction positions are 1,725 Class A shares directly and 3,997.35 credits. This is an administrative, non-cash accrual; actual impact depends on future service status and credit settlements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Directors' Deferred Compensation Share Credits | 17.168 | $325.89 | $6K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- Conversion price is not applicable to shares granted under the Outside Directors' Deferred Compensation Plan. Acquired under dividend reinvestment for Directors' Deferred Compensation Plan. The shares subject to this reporting are Share Credits which are periodically credited to the accounts of certain Directors of Erie Indemnity Company pursuant to its Outside Directors' Stock Plan. These Share Credits represent the right to receive an equivalent number of shares of Erie Indemnity Company Class A common stock when the reporting individual's service as a Director of the Company ends. There are no exercisable or expiration dates for these securities.